Literature DB >> 17729416

Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease.

Vassilios Koussoulas1, Spyridon Vassiliou, Ekaterini Spyridaki, Maria Demonakou, Ilia Vaki, Charalambos Barbatzas, Helen Giamarellou, Evangelos J Giamarellos-Bourboulis.   

Abstract

AIM: To investigate the role of gastric mucosa at the secretion of sTREM-1 in peptic ulcer.
METHODS: Seventy two patients were enrolled; 35 with duodenal, 21 with gastric ulcer and 16 with chronic gastritis. Patients were endoscoped and gastric juice was aspirated. Patients with duodenal and gastric ulcer underwent a second endoscopy post-treatment. Biopsies were incubated in the absence/presence of endotoxins or gastric juice. Supernatants were collected and sTREM-1 and TNFalpha were measured by enzyme immunoabsorbent assays. Scoring of gastritis was performed before and after treatment according to updated Sydney score.
RESULTS: Patients with duodenal and gastric ulcer and those with chronic gastritis had similar scores of gastritis. sTREM-1 was higher in supernatants of tissue samples of H pylori-positive than of H pylori-negative patients with gastric ulcer. Median (+/- SE) sTREM-1 was found increased in supernatants of patients with gastric ulcer before treatment (203.21 +/- 88.91 pg/1000 cells) compared to supernatants either from the same patients post-treatment (8.23 +/- 5.79 pg/1000 cells) or from patients with chronic gastritis (6.21 +/- 0.71 pg/1000 cells) (P < 0.001 and < 0.001, respectively). Similar differences for sTREM-1 were recorded among LPS-stimulated tissue samples of patients (P = 0.001). Similar differences were not found for TNFalpha. Positive correlations were found between sTREM-1 of supernatants from patients with both duodenal and gastric ulcer before treatment and the degree of infiltration of neutrophils and monocytes.
CONCLUSION: sTREM-1 secreted by the gastric mucosa is an independent mechanism connected to the pathogenesis of peptic ulcer. sTREM-1 was released at the presence of H pylori from the inflamed gastric mucosa in the field of gastric ulcer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17729416      PMCID: PMC4611837          DOI: 10.3748/wjg.v13.i34.4610

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  17 in total

Review 1.  ABC of the upper gastrointestinal tract: Pathophysiology of duodenal and gastric ulcer and gastric cancer.

Authors:  J Calam; J H Baron
Journal:  BMJ       Date:  2001-10-27

2.  Macrophages expressing triggering receptor expressed on myeloid cells-1 are underrepresented in the human intestine.

Authors:  Mirjam Schenk; Axel Bouchon; Stefan Birrer; Marco Colonna; Christoph Mueller
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

3.  Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease.

Authors:  Michalis Tzivras; Vassilios Koussoulas; Evangelos J Giamarellos-Bourboulis; Dimitrios Tzivras; Thomas Tsaganos; Pantelis Koutoukas; Helen Giamarellou; Athanasios Archimandritis
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

4.  Helicobacter pylori-related disease: guidelines for testing and treatment.

Authors:  W L Peterson; A M Fendrick; D R Cave; D A Peura; S M Garabedian-Ruffalo; L Laine
Journal:  Arch Intern Med       Date:  2000-05-08

5.  The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis.

Authors:  Sara Padol; Yuhong Yuan; Marroon Thabane; Ireneusz T Padol; Richard H Hunt
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

6.  Comparison of Helicobacter pylori infection and gastric mucosal histological features of gastric ulcer patients with chronic gastritis patients.

Authors:  Chuan Zhang; Nobutaka Yamada; Yun-Lin Wu; Min Wen; Takeshi Matsuhisa; Norio Matsukura
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

7.  Local cytokine response in Helicobacter pylori-infected subjects.

Authors:  C Lindholm; M Quiding-Järbrink; H Lönroth; A Hamlet; A M Svennerholm
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

Review 8.  Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology.

Authors:  A H Soll
Journal:  JAMA       Date:  1996-02-28       Impact factor: 56.272

Review 9.  Sensor molecules in intestinal innate immunity against bacterial infections.

Authors:  Lars Eckmann
Journal:  Curr Opin Gastroenterol       Date:  2006-03       Impact factor: 3.287

Review 10.  Helicobacter pylori and gastroduodenal pathology: new threats of the old friend.

Authors:  Niyaz Ahmed; Leonardo A Sechi
Journal:  Ann Clin Microbiol Antimicrob       Date:  2005-01-05       Impact factor: 3.944

View more
  4 in total

1.  Serum sTREM-1 as a surrogate marker of treatment outcome in patients with peptic ulcer disease.

Authors:  Vassilios Koussoulas; Evangelos J Giamarellos-Bourboulis; Charalambos Barbatzas; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2011-06-02       Impact factor: 3.199

2.  Implications for a role of interleukin-23 in the pathogenesis of chronic gastritis and of peptic ulcer disease.

Authors:  V Koussoulas; S Vassiliou; E J Giamarellos-Bourboulis; G Tassias; A Kotsaki; C Barbatzas; M Tzivras
Journal:  Clin Exp Immunol       Date:  2008-12-11       Impact factor: 4.330

3.  Comparison of gastric juice soluble triggering receptor expressed on myeloid cells and C-reactive protein for detection of Helicobacter pylori infection.

Authors:  Ahmad Piroozmand; Babak Soltani; Mohsen Razavizadeh; Amir Hasan Matini; Gholam Abbas Moosavi; Mohammad Salehi; Siamak Soltani
Journal:  Electron Physician       Date:  2017-12-25

4.  Serum soluble triggering receptor expressed on myeloid cells-1 in acute respiratory distress syndrome: a prospective observational cohort study.

Authors:  Ming-Tzer Lin; Yu-Feng Wei; Shih-Chi Ku; Chih-An Lin; Chao-Chi Ho; Chong-Jen Yu
Journal:  J Formos Med Assoc       Date:  2010-11       Impact factor: 3.282

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.